Indaptus Therapeutics, Inc.: Q1 2025 results
Published 14. 5. 2025, before the market opens. EPS -8,96 $ against an estimate of -5,04.
AI summary
AIThe summary shows how the results turned out, what the company delivered, the pros and cons and why the stock reacted the way it did. We do not have a press release for this quarter yet, so the summary would be based on the numbers alone.